184 related articles for article (PubMed ID: 24420527)
81. Prognostic impact of comorbidity in patients with bladder cancer.
Megwalu II; Vlahiotis A; Radwan M; Piccirillo JF; Kibel AS
Eur Urol; 2008 Mar; 53(3):581-9. PubMed ID: 17997024
[TBL] [Abstract][Full Text] [Related]
82. Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
Sathianathen NJ; Fan Y; Jarosek SL; Konety I; Weight CJ; Vinogradov S; Konety BR
Eur Urol Focus; 2020 Nov; 6(6):1180-1187. PubMed ID: 30797737
[TBL] [Abstract][Full Text] [Related]
83. The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients.
Aizawa R; Sakamoto M; Orito N; Kono M; Ogura M; Negoro Y; Sagoh T; Tsukahara K; Komatsu K; Noguchi M
Anticancer Res; 2017 Oct; 37(10):5761-5766. PubMed ID: 28982898
[TBL] [Abstract][Full Text] [Related]
84. Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients.
Su Q; Gao S; Lu C; Wu X; Zuo L; Zhang L
Urol Int; 2023; 107(1):46-57. PubMed ID: 34818263
[TBL] [Abstract][Full Text] [Related]
85. Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?
Froehner M; Koch R; Heberling U; Hübler M; Novotny V; Borkowetz A; Wirth MP; Thomas C
World J Urol; 2020 Mar; 38(3):695-702. PubMed ID: 31267181
[TBL] [Abstract][Full Text] [Related]
86. The relationship of travel distance with cystectomy access and outcomes.
Smith AB; Meyer AM; Meng K; Nielsen ME; Pruthi R; Wallen E; Woods M; Tan HJ
Urol Oncol; 2018 Jun; 36(6):308.e1-308.e9. PubMed ID: 29566978
[TBL] [Abstract][Full Text] [Related]
87. Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
Teo MTW; Dyrskjøt L; Nsengimana J; Buchwald C; Snowden H; Morgan J; Jensen JB; Knowles MA; Taylor G; Barrett JH; Borre M; Ørntoft TF; Bishop DT; Kiltie AE
Ann Oncol; 2014 Apr; 25(4):877-883. PubMed ID: 24623370
[TBL] [Abstract][Full Text] [Related]
88. The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.
Walraven JEW; Ripping TM; Oddens JR; van Rhijn BWG; Goossens-Laan CA; Hulshof MCCM; ; Kiemeney LA; Witjes JA; Lemmens VEPP; van der Hoeven JJM; Desar IME; Aben KKH; Verhoeven RHA
BJU Int; 2023 Feb; 131(2):244-252. PubMed ID: 35861125
[TBL] [Abstract][Full Text] [Related]
89. Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy.
Okada M; Shindo T; Fujino K; Maeda T; Ito N; Takahashi A; Hotta H; Kunishima Y; Matsukawa M; Takayanagi A; Wanifuchi A; Nofuji S; Kato R; Fukuta F; Hashimoto K; Kobayashi K; Tanaka T; Masumori N
Support Care Cancer; 2023 Oct; 31(10):607. PubMed ID: 37787829
[TBL] [Abstract][Full Text] [Related]
90. Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer.
Gurung PM; Veerakumarasivam A; Williamson M; Counsell N; Douglas J; Tan WS; Feber A; Crabb SJ; Short SC; Freeman A; Powles T; Hoskin PJ; West CM; Kelly JD
Int J Cancer; 2015 Feb; 136(3):709-20. PubMed ID: 24917520
[TBL] [Abstract][Full Text] [Related]
91. A mediation analysis to explain socio-economic differences in bladder cancer survival.
Russell B; Hemelrijck MV; Gårdmark T; Holmberg L; Kumar P; Bellavia A; Häggström C
Cancer Med; 2020 Oct; 9(20):7477-7487. PubMed ID: 32851811
[TBL] [Abstract][Full Text] [Related]
92. Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy.
Dell'Oglio P; Tian Z; Leyh-Bannurah SR; Trudeau V; Larcher A; Moschini M; Di Trapani E; Capitanio U; Briganti A; Montorsi F; Saad F; Karakiewicz PI
J Natl Compr Canc Netw; 2017 Mar; 15(3):327-333. PubMed ID: 28275033
[No Abstract] [Full Text] [Related]
93. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
Jazzar U; Yong S; Klaassen Z; Huo J; Hughes BD; Esparza E; Mehta HB; Kim SP; Tyler DS; Freedland SJ; Kamat AM; Wolf DV; Williams SB
Cancer; 2018 Aug; 124(15):3127-3135. PubMed ID: 29660813
[TBL] [Abstract][Full Text] [Related]
94. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands.
Bakens MJAM; Lemmens VEPP; de Hingh IHJT
HPB (Oxford); 2017 May; 19(5):443-448. PubMed ID: 28223043
[TBL] [Abstract][Full Text] [Related]
95. [Experience with radical surgery for muscle-invasive bladder cancer in patients with end-stage chronic kidney disease].
Pavlov VN; Pushkaryev AM; Safiullin RI; Kazikhinurov AA; Kondratenko YV; Alexeyev AV
Urologiia; 2016 Dec; (6):124-127. PubMed ID: 28248056
[TBL] [Abstract][Full Text] [Related]
96. Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?
Wolff I; Brookman-May S; May M
Curr Opin Urol; 2015 Sep; 25(5):418-26. PubMed ID: 26125505
[TBL] [Abstract][Full Text] [Related]
97. Socioeconomic status and survival outcomes in elderly cancer patients: A national health insurance service-elderly sample cohort study.
Jang BS; Chang JH
Cancer Med; 2019 Jul; 8(7):3604-3613. PubMed ID: 31066516
[TBL] [Abstract][Full Text] [Related]
98. Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia.
Patel MI; Bang A; Gillett D; Cheluvappa R; Smith DP
Cancer Med; 2015 Aug; 4(8):1145-52. PubMed ID: 25914165
[TBL] [Abstract][Full Text] [Related]
99. Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis.
Wilhite TJ; Routman D; Arnett AL; Glasgow AE; Habermann EB; Pisansky TM; Boorjian SA; Jethwa KR; Mynderse LA; Roberts KW; Frank I; Choo R; Davis BJ; Stish BJ
Bladder (San Franc); 2018; 5(3):e34. PubMed ID: 32775476
[TBL] [Abstract][Full Text] [Related]
100. Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival: A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe).
Häggström C; Rowley M; Liedberg F; Coolen ACC; Holmberg L
Cancer Med; 2023 Jun; 12(12):13856-13864. PubMed ID: 37096787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
